Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Amicus Therapeutics
4118
Amicus Therapeutics
Health Care
Technology
Biotechnology
Biotech
Suggest edits
Founded
2002
Raised
$41M
Follow us
Companies in the same industry
XO1
Capella BioScience
Fusion Genomics
WindGap Medical
BIOTRICITY INC.
Cancer Treatment Services International
Rgenix
InGeneron Incorporated
Lysosomal Therapeutics
Athersys Inc
Alexa global traffic share
Twitter followers
Overview
Funding
2
Acquisitions
2
Add info
Latest funding
$10,000,000
Debt financing - 2013
$31,000,000
Venture capital (Series B) - 2004
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
the home of AI info
Comparing of Amicus Therapeutics Inc. (FOLD) and Minerva Neurosciences Inc. (NASDAQ:NERV)
Xconomy
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement
Health
Science
Xconomy
Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition
Health
Xconomy
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug
Health
The Motley Fool
Why Amicus Therapeutics, Inc. Stock Slumped 14.0% in April
The Motley Fool
What Caused Amicus Therapeutics Shares To Skyrocket 23% Last Month
Health
Stock markets
The Motley Fool
Amicus Therapeutics Closes In on a 9-Figure Opportunity
The Motley Fool
3 Emerging Biotech Stocks I'm Watching Like a Hawk
The Motley Fool
Why Amicus Therapeutics Shares Are Skyrocketing Again Today
Stock markets
The Motley Fool
Why Amicus Therapeutics Shares Are Up Today
Stock markets
The Motley Fool
Why Amicus Therapeutics Shares Are Soaring 10% Today --
Stock markets
Health
